DOCSLIB.ORG

M the Battle Against Neglected Tropical Diseases Forging the Chain “Results Innovative Build Trust, and with Intensified Trust, Commitment Management Escalates.”

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
M the Battle Against Neglected Tropical Diseases Forging the Chain “Results Innovative Build Trust, and with Intensified Trust, Commitment Management Escalates.” SCENES FROM THE BATTLE AGAINST NEGLECTED TROPICAL DISEASES FORGING THE CHAIN “RESULTS INNOVATIVE BUILD TRUST, AND WITH INTENSIFIED TRUST, COMMITMENT MANAGEMENT ESCALATES.” Dr Margaret Chan, WHO Director-General “RESULTS INNOVATIVE BUILD TRUST, AND WITH INTENSIFIED TRUST, COMMITMENT MANAGEMENT ESCALATES.” Dr Margaret Chan, WHO Director-General WHO Library Cataloguing-in-Publication Data Forging the chain: scenes from the battle against neglected tropical diseases, with the support of innovative partners. 1. Tropical Medicine 2. Neglected Diseases I. World Health Organization ISBN 978 92 4 151000 4 (NLM classification: WC 680) © World Health Organization 2016 Acknowledgements All rights reserved. Publications of the World Health Organization are available on the WHO website Forging the chain: scenes from the battle against neglected tropical diseases (with the support of (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, innovative partners) was prepared by the Innovative and Intensified Disease Management (IDM) unit 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). of the WHO Department of Control of Neglected Tropical Diseases under the overall coordination and supervision of Dr Jean Jannin. Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website The writing team was coordinated by Deboh Akin-Akintunde and Lise Grout, in collaboration with (www.who.int/about/licensing/copyright_form/en/index.html). Grégoire Rigoulot Michel, Pedro Albajar Viñas, Kingsley Asiedu, Daniel Argaw Dagne, Jose Ramon Franco Minguell, Stéphanie Jourdan, Raquel Mercado, Gerardo Priotto, Prabha Rajamani, Jose The designations employed and the presentation of the material in this publication do not imply the Antonio Ruiz Postigo, Danilo Salvador and Patricia Scarrott. expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation Appreciation is extended to the Ministries of Health, donors, partners, foundations, pharmaceutical of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines companies donating medicines, nongovernmental organizations, research centres, academia and for which there may not yet be full agreement. Maps on page 107 are from Service Commun de colleagues for their generosity and contributions to IDM activities. Lutte contre les grandes endémies. Rapport d'activité depuis sa création (Activity report since its creation). Médecin Général Pierre Richet, octobre 1958 (report prepared from the 12th session of Given the space constraints and the large number of contributors, their names have been omitted the regional committee in Brazzaville). All photographs are from WHO except on pages 18 – 19, 22, but their involvement and commitment are gratefully acknowledged. 30 – 31, 36 – 37, 38, 39, 42, 46 – 47, 68 – 69, 74 and 106 (Patrick Robert) and pages 86, 100 – 101 and 110 (Lâm Duc Hiên). The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the infor- mation contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Art direction and design by Carl Guilhon, Guillaume Peitrequin, Atelier Roger Pfund. Offset printing by Moléson Impressions. Printed in Switzerland. WHO/HTM/NTD/IDM/2016.01 WHO Library Cataloguing-in-Publication Data Forging the chain: scenes from the battle against neglected tropical diseases, with the support of innovative partners. 1. Tropical Medicine 2. Neglected Diseases I. World Health Organization ISBN 978 92 4 151000 4 (NLM classification: WC 680) © World Health Organization 2016 Acknowledgements All rights reserved. Publications of the World Health Organization are available on the WHO website Forging the chain: scenes from the battle against neglected tropical diseases (with the support of (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, innovative partners) was prepared by the Innovative and Intensified Disease Management (IDM) unit 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). of the WHO Department of Control of Neglected Tropical Diseases under the overall coordination and supervision of Dr Jean Jannin. Requests for permission to reproduce or translate WHO publications – whether for sale or for non-commercial distribution – should be addressed to WHO Press through the WHO website The writing team was coordinated by Deboh Akin-Akintunde and Lise Grout, in collaboration with (www.who.int/about/licensing/copyright_form/en/index.html). Grégoire Rigoulot Michel, Pedro Albajar Viñas, Kingsley Asiedu, Daniel Argaw Dagne, Jose Ramon Franco Minguell, Stéphanie Jourdan, Raquel Mercado, Gerardo Priotto, Prabha Rajamani, Jose The designations employed and the presentation of the material in this publication do not imply the Antonio Ruiz Postigo, Danilo Salvador and Patricia Scarrott. expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation Appreciation is extended to the Ministries of Health, donors, partners, foundations, pharmaceutical of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines companies donating medicines, nongovernmental organizations, research centres, academia and for which there may not yet be full agreement. Maps on page 107 are from Service Commun de colleagues for their generosity and contributions to IDM activities. Lutte contre les grandes endémies. Rapport d'activité depuis sa création (Activity report since its creation). Médecin Général Pierre Richet, octobre 1958 (report prepared from the 12th session of Given the space constraints and the large number of contributors, their names have been omitted the regional committee in Brazzaville). All photographs are from WHO except on pages 18 – 19, 22, but their involvement and commitment are gratefully acknowledged. 30 – 31, 36 – 37, 38, 39, 42, 46 – 47, 68 – 69, 74 and 106 (Patrick Robert) and pages 86, 100 – 101 and 110 (Lâm Duc Hiên). The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by the World Health Organization to verify the infor- mation contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. Art direction and design by Carl Guilhon, Guillaume Peitrequin, Atelier Roger Pfund. Offset printing by Moléson Impressions. Printed in Switzerland. WHO/HTM/NTD/IDM/2016.01 ABBREVIATIONS 7 CIRDES DNDI ↓ ↓ CENTRE DRUGS FOR INTERNATIONAL NEGLECTED DE RECHERCHE- DISEASES INITIATIVE DÉVELOPPEMENT SUR L’ELEVAGE FAO EN ZONES ↓ SUBHUMIDES FOOD AND AGRICULTURE DDT ORGANIZATION ↓ OF THE UNITED DICHLORODIPHENYL- NATIONS TRICHLOROETHANE GPS DNA ↓ ↓ GLOBAL DEOXYRIBONUCLEIC POSITIONING ACID SYSTEM ABBREVIATIONS 7 CIRDES DNDI ↓ ↓ CENTRE DRUGS FOR INTERNATIONAL NEGLECTED DE RECHERCHE- DISEASES INITIATIVE DÉVELOPPEMENT SUR L’ELEVAGE FAO EN ZONES ↓ SUBHUMIDES FOOD AND AGRICULTURE DDT ORGANIZATION ↓ OF THE UNITED DICHLORODIPHENYL- NATIONS TRICHLOROETHANE GPS DNA ↓ ↓ GLOBAL DEOXYRIBONUCLEIC POSITIONING ACID SYSTEM 8 HAT NGO 9 ↓ ↓ HUMAN AFRICAN ITM NONGOVERNMENTAL TRYPANOSOMIASIS ↓ ORGANIZATION INSTITUTE OF SSNCP HIV/AIDS TROPICAL MEDICINE NTD ↓ ↓ ↓ SLEEPING SICKNESS HUMAN MSF NEGLECTED NATIONAL IMMUNODEFICIENCY ↓ TROPICAL CONTROL VIRUS/ACQUIRED MÉDECINS SANS DISEASE PROGRAMME IMMUNODEFICIENCY FRONTIÈRES SYNDROME PCR WHA NECI ↓ ↓ IDM ↓ POLYMERASE WORLD HEALTH ↓ NON-ENDEMIC CHAIN REACTION ASSEMBLY INNOVATIVE AND COUNTRIES INTENSIFIED INITIATIVE PPV WHO DISEASE ↓ ↓ MANAGEMENT NECT POSITIVE WORLD HEALTH ↓ PREDICTIVE VALUE ORGANIZATION IRD NIFURTIMOX- ↓ EFLORNITHINE STI INSTITUT DE COMBINATION ↓ RECHERCHE THERAPY SWISS TROPICAL POUR LE INSTITUTE DÉVELOPPEMENT 8 HAT NGO 9 ↓ ↓ HUMAN AFRICAN ITM NONGOVERNMENTAL TRYPANOSOMIASIS ↓ ORGANIZATION INSTITUTE OF SSNCP HIV/AIDS TROPICAL MEDICINE NTD ↓ ↓ ↓ SLEEPING SICKNESS HUMAN MSF NEGLECTED NATIONAL IMMUNODEFICIENCY ↓ TROPICAL CONTROL VIRUS/ACQUIRED MÉDECINS SANS DISEASE PROGRAMME IMMUNODEFICIENCY FRONTIÈRES SYNDROME PCR WHA NECI ↓ ↓ IDM ↓ POLYMERASE WORLD
Load more

Recommended publications
  • Health Information for International Travel 1996-97
    CDCCENTERS FOR DISEASE CONTROL AND PREVENTION Health Information for International Travel 1996-97 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service This document was created with FrameMaker 4.0.4 ATTENTION READERS It is impossible for an annual publication on international travel to remain absolutely current given the nature of disease transmission in the world today. For readers of this text to be the most up-to-date on travel-related diseases and recommendations, this text must be used in conjunction with the other services provided by the Travelers’ Health Section of the Centers for Disease Control and Prevention (CDC). Changes such as vaccine requirements, disease outbreaks, drug availability, or emerging infections will be posted promptly on these services. For these and other changes, please consult either our Voice or Fax Information Service at 404-332-4559 or our Internet address on the World Wide Web Server at http://www.cdc.gov or the File Transfer Protocol server at ftp.cdc.gov . Because certain countries require vaccination against yellow fever only if a traveler arrives from a country currently infected with this disease, it is essential that up-to-date information regarding infected areas be maintained for reference. The CDC publishes a biweekly "Summary of Health Information for Interna- tional Travel" (Blue Sheet) which lists yellow fever infected areas. Subscriptions to the Blue Sheet are available to health departments, physicians, travel agencies, international airlines, shipping companies, travel clinics, and other private and public agencies that advise international travelers concerning health risks they may encounter when visiting other countries.
    [Show full text]
  • That Historical Plague Was Pure Epidemics of Primary Pneumonic Plague
    CHAPTER THIRTEEN GUNNAR KARLSSON’S ALTERNATIVE THEORY: THAT HISTORICAL PLAGUE WAS PURE EPIDEMICS OF PRIMARY PNEUMONIC PLAGUE Introduction G. Karlsson presented his alternative theory to the international com- munity of scholars in a paper published in Journal of Medieval History in 1996 where he argues that two late medieval epidemics in Iceland and more generally that plague in medieval Europe were pure epidem- ics of primary pneumonic plague.1 For his epidemiological interpreta- tion, Karlsson bases his alternative theory directly on Morris’s assertion of the occurrence of pure epidemics of primary pneumonic plague, a modality of plague disease spread by interhuman cross-infection by droplets. Th e concept of a pure epidemic of primary pneumonic plague implies that the origin of the epidemic is not a case of bubonic plague which develops secondary pneumonia but a case in which the fi rst vic- tim contracted pneumonic plague directly by inhalation of infected droplets into the lungs. Karlsson’s paper follows quite closely and draws heavily on a paper he published together with S. Kjartansson in an Icelandic journal in 1994 on two supposed plague epidemics in Iceland in 1402–4 and 1494–5 respectively.2 He is clear about its objective: “Th e present article [as the fi rst in Icelandic] can be seen as a defence of the late Jón Steff ensen against Benedictow’s critique of his conclusions,” namely, that these epidemics, and also the Black Death of 1348–9 in Norway were primary pneumonic plague.3 Th us, the central feature of Karlsson’s (and Karlsson’s and Kjartansson’s) paper on the two supposed plague epidemics in fi ft eenth-century Iceland is a comprehensive and sharp criticism of my doctoral thesis (1993, repr.
    [Show full text]
  • Autophagy in Trypanosomatids
    Cells 2012, 1, 346-371; doi:10.3390/cells1030346 OPEN ACCESS cells ISSN 2073-4409 www.mdpi.com/journal/cells Review Autophagy in Trypanosomatids Ana Brennand 1,†, Eva Rico 2,†,‡ and Paul A. M. Michels 1,* 1 Research Unit for Tropical Diseases, de Duve Institute, Université catholique de Louvain, Avenue Hippocrate 74, postal box B1.74.01, B-1200 Brussels, Belgium; E-Mail: [email protected] 2 Department of Biochemistry and Molecular Biology, University Campus, University of Alcalá, Alcalá de Henares, Madrid, 28871, Spain; E-Mail: [email protected] † These authors contributed equally to this work. ‡ Present Address: Centre for Immunity, Infection and Evolution, Institute of Immunology and Infection Research, School of Biological Sciences, King’s Buildings, University of Edinburgh, West Mains Road, Edinburgh EH9 3JT, UK. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +32-2-7647473; Fax: +32-2-7626853. Received: 28 June 2012; in revised form: 14 July 2012 / Accepted: 16 July 2012 / Published: 27 July 2012 Abstract: Autophagy is a ubiquitous eukaryotic process that also occurs in trypanosomatid parasites, protist organisms belonging to the supergroup Excavata, distinct from the supergroup Opistokontha that includes mammals and fungi. Half of the known yeast and mammalian AuTophaGy (ATG) proteins were detected in trypanosomatids, although with low sequence conservation. Trypanosomatids such as Trypanosoma brucei, Trypanosoma cruzi and Leishmania spp. are responsible for serious tropical diseases in humans. The parasites are transmitted by insects and, consequently, have a complicated life cycle during which they undergo dramatic morphological and metabolic transformations to adapt to the different environments.
    [Show full text]
  • Programme Against African Trypanosomiasis Year 2006 Volume
    ZFBS 1""5 1SPHSBNNF *44/ WPMVNF "HBJOTU "GSJDBO QBSU 5SZQBOPTPNJBTJT 43%43%!.$4290!./3/-)!3)3).&/2-!4)/. $EPARTMENTFOR )NTERNATIONAL $EVELOPMENT year 2006 PAAT Programme volume 29 Against African part 1 Trypanosomiasis TSETSE AND TRYPANOSOMIASIS INFORMATION Numbers 13466–13600 Edited by James Dargie Bisamberg Austria FOOD AND AGRICULTURE ORGANIZATION OF THE UNITED NATIONS Rome, 2006 The designations employed and the presentation of material in this information product do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations concerning the legal or development status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. All rights reserved. Reproduction and dissemination of material in this in- formation product for educational or other non-commercial purposes are authorized without any prior written permission from the copyright holders provided the source is fully acknowledged. Reproduction of material in this information product for resale or other commercial purposes is prohibited without written permission of the copyright holders. Applications for such permission should be addressed to the Chief, Electronic Publishing Policy and Support Branch, Information Division, FAO, Viale delle Terme di Caracalla, 00100 Rome, Italy or by e-mail to [email protected] © FAO 2006 Tsetse and Trypanosomiasis Information Volume 29 Part 1, 2006 Numbers 13466–13600 Tsetse and Trypanosomiasis Information TSETSE AND TRYPANOSOMIASIS INFORMATION The Tsetse and Trypanosomiasis Information periodical has been established to disseminate current information on all aspects of tsetse and trypanosomiasis research and control to institutions and individuals involved in the problems of African trypanosomiasis.
    [Show full text]
  • Literature on Ṭāʿūn/Plague Treatises* Mustakim Arıcı** Translated by Faruk Akyıldız***
    Silent Sources of the History of Epidemics in the Islamic World: Literature on Ṭāʿūn/Plague Treatises* Mustakim Arıcı** Translated by Faruk Akyıldız*** Abstract From 1347 onwards, new literature emerged in the Islamic and Western worlds: the Ṭā‘ūn [Plague] Treatises. The literature in Islamdom was underpinned by three things: (i) Because the first epidemic was a phenomenon that had been experienced since the birth of Islam, ṭā‘ūn naturally occurred on the agenda of hadith sources, prophetic biography, and historical works. This agenda was reflected in the treatises as discussions around epidemics, particularly plague, as well as the fight against disease in general in a religious and jurisprudential framework. (ii) Works aimed at diagnosing the plague and dealing with various aspects of it tried to explain disease on the basis of Galenic-Avicennian medicine within the framework of miasma theory, thus deriving their basis from this medical paradigm. (iii) Finally, the encounter with such a brutal illness prompted a quest for all possible remedies, including the occultist culture. This background shaped the language and content of the treatises at different levels. This article first evaluates the modern studies on plague treatises written in the Islamic world. Then, it surveys the Islamic historical sources in order to pin down the meaning they assign to the concepts of wabā’ [epidemic disease] and ṭā‘ūn [plague]. Certain medical works that were the resources for medical doctrines and terminology for plague treatises are also evaluated with a focus on these two concepts. Thus, the aim of this survey is to understand the general conception of epidemic disease and plague in the Islamic world before the Black Death (1346-1353).
    [Show full text]
  • Covid-19-Revisiting-Daniel-Defoe
    UCL MEDICAL ANTHROPOLOGY Consciously Quarantined: A COVID-19 response from the Social Sciences, April 2020 Revisiting Defoe, or: Why History Matters in the Time of Covid-19 CATHERINE TOURANGEAU Why should history matter in times of crisis? The question is worth pondering. Historians and history teachers are not on the front lines, fighting for people’s lives or providing food and medical supplies. Even their valuable knowledge and understanding of the crises of the past can seem useless and impractical. Every epidemic is different, after all; we can’t very well apply the methods of former times to the current crisis. And yet—history sheds crucial light on the dynamics and behaviors of epidemics over time and space. Studying the experience of our predecessors often offers much-needed lessons in humility and humanity. In the long list of epidemics that have hit western societies over the centuries, the Great Plague of London, which claimed the lives of 100,000 people in the mid-1660s, is perhaps not the obvious case to delve into. The Spanish flu pandemic of 1918 and the HIV/Aids pandemic of the 1980s certainly seem more relevant to the current situation. And yet, despite its greater distance in time, the plague epidemic of 1665 highlights a number of significant patterns common to modern epidemics. It also reminds us that even the darkest of human crises eventually give way to luminous days. Compared to most early modern epidemics, the plague of 1665 left a very wide range of documentary traces. Modern historians, indeed, have access to official orders and laws; statistical data and news bulletins; medical and religious treatises; poems and prayers; and even cartoons and works of art.
    [Show full text]
  • The Socionomist a Monthly Publication Designed to Help Readers Understand and Prepare for Major Changes in Social Mood
    The Socionomist A monthly publication designed to help readers understand and prepare for major changes in social mood May 2013 WINNINGS MIRROR DJIA TO A TEE 3 Mood Riffs: Shifting opinions affect women, Spain’s royals and for-profit universities. 5 A 19th Century bear market played a key role in how we look at disease today. 9 Presenters and attendees share their take on the 2013 Socionomics Summit. PO Box 1618 • Gainesville, GA 30503 USA A publication of the Socionomics Institute 770-536-0309 • 800-336-1618 • FAX 770-536-2514 www.socionomics.net © 2013 e289533 SOCIONOMICS INSTITUTE The Socionomist—May 2013 Golf Links to Social Mood By Peter Kendall The Elliott Wave Theorist first documented LPGA ratio reveals a consistently more dominant “golf’s pedigree as one of the great bull market role of women in bear market phases (see Figure 3). games” in October 1997. EWT traced the game’s As the Dow triple-topped near 1000 (in nominal rise from an initial boom in the Roaring ‘20s up terms) from 1966 to 1973, male supremacy, repre- through the 1990s, coincident with every major up- sented by higher PGA/LPGA winnings ratio, result- ward surge in stock prices. At that time, the mania ed in the leading male golfer earning six times that for stocks was on, and its alignment with the boom- of the LPGA leading money winner. By the end of ing popularity of golf was so tight that many busi- the bear market in 1982, on the other hand, the ratio ness publications, such as The Wall Street Journal, approached parity, only to rise dramatically again Business Week and Barron’s, added golfing supple- to between four and six times as the Dow registered ments.
    [Show full text]
  • The Political Scar of Epidemics
    NBER WORKING PAPER SERIES THE POLITICAL SCAR OF EPIDEMICS Barry Eichengreen ⓡ Orkun Saka ⓡ Cevat Giray Aksoy Working Paper 27401 http://www.nber.org/papers/w27401 NATIONAL BUREAU OF ECONOMIC RESEARCH 1050 Massachusetts Avenue Cambridge, MA 02138 June 2020, Revised April 2021 All authors contributed equally to this manuscript and the order of author names is randomized via AEA Randomization Tool (code: 5OQ1MZC1Jbmd). Eichengreen is a Professor of Economics and Political Science at the University of California, Berkeley, Research Associate at the National Bureau of Economic Research and Research Fellow at the Centre for Economic Policy Research. Saka is an Assistant Professor at the University of Sussex, Visiting Fellow at the London School of Economics, Research Associate at the Systemic Risk Centre and Research Affiliate at CESifo. Aksoy is a Principal Economist at the European Bank for Reconstruction and Development (EBRD), Assistant Professor of Economics at King’s College London and Research Associate at IZA Institute of Labour Economics. We thank Nicolás Ajzenman, Chris Anderson, Belinda Archibong, Sascha Becker, Damien Bol, Ralph De Haas, Anna Getmansky, Luigi Guiso, Beata Javorcik, André Sapir, Konstantin Sonin, Dan Treisman, and webinar participants at the Bank of Finland, CESifo Workshop on Political Economy, City, University of London, Comparative Economics Webinar series, EBRD, EUI Political Behaviour Colloquium, LSE and University of Sussex for helpful comments. We are also grateful to Kimiya Akhyani for providing very useful research assistance. Views presented are those of the authors and not necessarily those of the EBRD. All interpretations, errors, and omissions are our own. The views expressed herein are those of the authors and do not necessarily reflect the views of the National Bureau of Economic Research.
    [Show full text]
  • Modelling Interacting Epidemics in Overlapping Populations
    Modelling Interacting Epidemics in Overlapping Populations Marily Nika1, Dieter Fiems2, Koen de Turck2, and William J. Knottenbelt1 1 Department of Computing, Imperial College London, London SW7 2AZ, United Kingdom, Email: fmarily,[email protected] 2 Ghent University, Department TELIN, St-Pietersnieuwstraat 41, 9000 Gent, Belgium Email: fdieter.fiems,[email protected] Abstract. Epidemic modelling is fundamental to our understanding of biological, social and technological spreading phenomena. As conceptual frameworks for epidemiology advance, it is important they are able to elucidate empirically-observed dynamic feedback phenomena involving interactions amongst pathogenic agents in the form of syndemic and counter-syndemic effects. In this paper we model the dynamics of two types of epidemics with syndemic and counter-syndemic interaction ef- fects in multiple possibly-overlapping populations. We derive a Markov model whose fluid limit reduces to a set of coupled SIR-type ODEs. Its numerical solution reveals some interesting multimodal behaviours, as shown in our case studies. Keywords: Epidemics, Social Networks, Syndemic, Counter-syndemic 1 Introduction You think because you understand `one' you must also understand `two', because one and one make two. But you must also understand `and'... Rumi (13th century Persian Poet) Epidemics of various kinds have been an important focus of study throughout human history. As health care standards have risen and information technology has advanced over the past half century, our preoccupation with epidemics of a biological nature has lessened while our obsession with epidemics of a social and technological nature has dramatically increased. This has been accompanied by a growing realisation that many of the epidemiological techniques used in the modelling of biological diseases can be readily transplanted into social and tech- nological domains such as content and information diffusion, rumour spreading, gossiping protocols and viral marketing.
    [Show full text]
  • Plants As Sources of Anti-Protozoal Compounds
    PLANTS AS SOURCES OF ANTI- PROTOZOAL COMPOUNDS Thesis presented by Angela Paine for the degree of Doctor of Philosophy in the Faculty of Medicine of the University of London Department of Pharmacognosy The School of Pharmacy University of London 1995 ProQuest Number: 10104878 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest. ProQuest 10104878 Published by ProQuest LLC(2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code. Microform Edition © ProQuest LLC. ProQuest LLC 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106-1346 dedicated to my late father Abstract The majority of the world's population relies on traditional medicine, mainly plant-based, for the treatment of disease. This study focuses on plant remedies used to treat tropical diseases caused by protozoan parasites. The following protozoal diseases: African trypanosomiasis, leishmaniasis. South American trypanosomiasis and malaria, and the traditional use of plant remedies in their treatment, are reviewed in a world wide context. In the present work, vector and mammalian forms of Trypanosoma b. brucei, the vector forms of Leishmania donovani and Trypanosoma cruzi and the mammalian forms of Plasmodium falciparum were maintained in culture in vitro in order to evaluate the activity of a series of plant extracts, pure natural products and synthetic analogues against these protozoan parasites in vitro.
    [Show full text]
  • Human Trypanosomiasis in India: Is It an Emerging New Zoonosis?
    Chapter 4 Human Trypanosomiasis in India: Is it an Emerging New Zoonosis? Prashant P Joshi HUMAN TRYPANOSOMIASIS Trypanosomes are flagellated protozoan parasites infecting man (human trypanosomiasis) and a wide range of animals (animal trypanosomiasis) (Figures 1 and 6). Human trypanosomiasis is confined to Sub-Saharan Africa and Latin America and exists in two forms: 1. Human African trypanosomiasis (HAT) (sleeping sickness) is endemic in Sub-Saharan Africa. It is a dreadful fatal disease and was responsible for devastating epidemics in 1920s, with resurgence in 1990s. It is caused by Trypanosoma brucei (T.b.) gambiense (chronic form) or Trypanosoma brucei rhodesiense (acute form) and 2. American trypanosomiasis (Chagas disease) caused by T. cruzi is endemic in Latin America. Both diseases are transmitted by vectors: Human African Trypanosomiasis by infected saliva of Tsetse fly, and chagas by infected feces of bugs (Figure 2). Clinically, HAT has two Figure 2: Tsetse fly—the vector for HAT is not found in India stages: Stage 1 or hemolymphatic stage characterized by fever, cervical lymphadenopathy, especially in the posterior triangle (Winterbottom’s sign), splenomegaly, rash, pruritus, muscular pain, anemia, thrombocytopenia and carditis, which can sometimes be fatal. This is followed by stage two, the neurological phase or the meningoencephalitic stage with CNS invasion, in which there is marked sleep disturbance characterized by day-time somnolence and night-time insomnia. However, human trypanosomiasis of neither the kind which is evidenced in Africa and America, nor their vectors is found in India. ANIMAL TRYPANOSOMIASIS In contrast to human trypanosomiasis, animal trypano-somiasis has a worldwide distribution and is common in India.
    [Show full text]
  • Coronavirus and Recent Market Volatility
    Coronavirus and Recent Market Volatility WHAT IS IT? Coronaviruses are a category of viruses that cause respiratory illness. This includes viruses like the common cold and flu. These can originate in animals and can occasionally infect people. MERS and SARS are a couple examples of types of a coronavirus. This new specific strain, the COVID-19, was first reported in Wuhan, China in December 2019. While officials are still unsure of how the disease was spread to humans, the infection is believed to have come from wildlife that was sold at a local farmer’s market. Wuhan is the 11th largest city in China and is home to more than 11 million people. WHAT ARE THE SYMPTOMS? According to the World Health Organization, some of the symptoms include aches and pains, fever, cough, runny nose, shortness of breath and breathing difficulties. In severe cases, infection can cause pneumonia, severe acute respiratory syndrome, kidney failure and even death. HOW BIG OF A PROBLEM IS THIS? Number of New Confirmed Cases Declining According to the World Health Organization, the number of people infected globally has exceeded 80,000 and the number of deaths total more than 2,700. As of February 25, the World Health Organization states that it is still too early to declare the coronavirus a pandemic. The definition of a pandemic is an epidemic that occurs over a wide geographic area and affects an exceptionally high proportion of the global population. While we are not trying to minimize the severity of this outbreak, it is important to put the magnitude of this virus into context.
    [Show full text]